U.S. Markets open in 4 hrs 27 mins
  • S&P Futures

    4,404.00
    +55.00 (+1.26%)
     
  • Dow Futures

    34,516.00
    +331.00 (+0.97%)
     
  • Nasdaq Futures

    14,386.25
    +245.50 (+1.74%)
     
  • Russell 2000 Futures

    2,028.30
    +27.00 (+1.35%)
     
  • Crude Oil

    86.09
    +0.49 (+0.57%)
     
  • Gold

    1,847.70
    -4.80 (-0.26%)
     
  • Silver

    23.95
    +0.05 (+0.23%)
     
  • EUR/USD

    1.1291
    -0.0015 (-0.1355%)
     
  • 10-Yr Bond

    1.7830
    0.0000 (0.00%)
     
  • Vix

    28.74
    -0.11 (-0.38%)
     
  • GBP/USD

    1.3509
    +0.0003 (+0.0257%)
     
  • USD/JPY

    114.1030
    +0.2370 (+0.2081%)
     
  • BTC-USD

    37,708.80
    +1,257.06 (+3.45%)
     
  • CMC Crypto 200

    857.36
    +46.76 (+5.77%)
     
  • FTSE 100

    7,493.49
    +122.03 (+1.66%)
     
  • Nikkei 225

    27,011.33
    -120.01 (-0.44%)
     

Trade Alert: The Independent Director Of National Health Investors, Inc. (NYSE:NHI), Robert Webb, Has Just Spent US$156k Buying 2.9% More Shares

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • NHI

Potential National Health Investors, Inc. (NYSE:NHI) shareholders may wish to note that the Independent Director, Robert Webb, recently bought US$156k worth of stock, paying US$52.02 for each share. While that's a very decent purchase to our minds, it was proportionally a bit modest, boosting their holding by just 2.9%.

Check out our latest analysis for National Health Investors

National Health Investors Insider Transactions Over The Last Year

In fact, the recent purchase by Independent Director Robert Webb was not their only acquisition of National Health Investors shares this year. Earlier in the year, they paid US$57.50 per share in a US$172k purchase. That means that an insider was happy to buy shares at above the current price of US$53.46. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. In our view, the price an insider pays for shares is very important. It is generally more encouraging if they paid above the current price, as it suggests they saw value, even at higher levels.

While National Health Investors insiders bought shares during the last year, they didn't sell. The chart below shows insider transactions (by companies and individuals) over the last year. By clicking on the graph below, you can see the precise details of each insider transaction!

insider-trading-volume
insider-trading-volume

National Health Investors is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying.

Insider Ownership of National Health Investors

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. Insiders own 4.0% of National Health Investors shares, worth about US$99m. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.

So What Do The National Health Investors Insider Transactions Indicate?

It is good to see recent purchasing. We also take confidence from the longer term picture of insider transactions. Given that insiders also own a fair bit of National Health Investors we think they are probably pretty confident of a bright future. While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. When we did our research, we found 3 warning signs for National Health Investors (1 is a bit concerning!) that we believe deserve your full attention.

But note: National Health Investors may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.